Some limitations on emergency contraception are eased

Article

The FDA approved a new one-pill formulation of the emergency contraceptive Plan B in July.

The Food and Drug Administration (FDA) approved a new one-pill formulation of the emergency contraceptive (EC) Plan B in July. Called Plan B One-Step, the product is available behind the counter without a prescription to women 17 or older. The FDA also recently approved Next Choice, a generic version of the original two-pill Plan B formulation, which is obtainable by prescription to those 17 or younger.

The American College of Obstetricians and Gynecologists (ACOG) praised the recent FDA actions, saying the new formulation "will simplify this important pregnancy prevention treatment" (ACOG press release, 7/15/09). However, ACOG also reiterated its "long-held position that there is no valid scientific or medical reason to impose an age restriction on the availability of EC because it is safe and effective for adolescents and women of all ages." It urged the FDA "to withdraw the age restriction altogether and eliminate the behind-the-counter status for EC."

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.